Inhibition of Cyclic Nucleotide Phosphodiesterases by Methylxanthines and Related Compounds-Reference-Cited by-同舟云学术

Inhibition of Cyclic Nucleotide Phosphodiesterases by Methylxanthines and Related Compounds

Published:2010-08-19 Issue: Volume: Page:93-133
ISSN:0171-2004
Container-title:Methylxanthines
language:
Short-container-title:

Author:

Francis Sharron H.,Sekhar Konjeti R.,Ke Hengming,Corbin Jackie D.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-13443-2_4

Reference196 articles.

1. Al-Ameri H, Thomas ML, Yoon A, Mayeda GS, Burstein S, Kloner RA, Shavelle DM (2009) Complication rate of diagnostic carotid angiography performed by interventional cardiologists. Catheter Cardiovasc Interv 73:661–665

2. Arnaud M (2010) Pharmacokinetics and metabolism of natural methylxanthines in animal and man. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg

3. Aviado DM, Porter JM (1984) Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy 4:297–307

4. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164–2171

5. Barnes PJ (2003a) Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167:813–818

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of caffeine and its effects on the human body;European Journal of Medicinal Chemistry Reports;2024-04

2. Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis;Cancer Research;2023-06-19

3. Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages;Pharmaceuticals;2023-05-11

4. Molecular modeling studies of fused pyrimidine derivatives at various receptors;Fused Pyrimidine-Based Drug Discovery;2023

5. Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules;Frontiers in Pharmacology;2022-11-24